A new device to reduce aerosol exposure during nasal surgeries
Development of a novel kit for reduction of aerosolized particles during endonasal surgeries: the PharynVac Device
This study is testing a new device called PharynVac that helps make sinus surgeries safer for both patients and doctors by reducing germs and improving visibility during the procedure.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pharynvac Surgical Technology INC. NIH-funded |
| Lab location | 1 site (Brooklyn, United States) |
| Project ID | NIH-10922180 on NIH RePORTER |
What this research studies
This research focuses on developing the PharynVac device, which aims to improve safety during sinonasal surgeries by reducing exposure to pathogens and toxins for surgical staff, minimizing blood ingestion by patients, and enhancing visibility during procedures. The device works by using a balloon aspiration catheter that addresses these issues simultaneously. The research will involve testing the device's effectiveness and safety in both laboratory models and large animal studies before moving on to human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals scheduled for sinonasal surgeries who may benefit from reduced risks associated with these procedures.
Not a fit: Patients undergoing surgeries unrelated to the sinonasal area or those who do not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer sinonasal surgeries with fewer complications for both patients and surgical staff.
How similar studies have performed: While the approach of using a device like PharynVac is innovative, similar devices aimed at improving surgical safety have shown promise in other surgical fields.
Where this research is happening
Brooklyn, United States
- Pharynvac Surgical Technology INC. — Brooklyn, United States (Active)
Researchers
- Principal investigator: Iloreta, Alfred-Marc — Pharynvac Surgical Technology INC.
- Study coordinator: Iloreta, Alfred-Marc
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.